Decision

UK REACH authorisations for Siemens Healthcare Diagnostics Products GmbH, 3 July 2024

Decision on application for authorisations under UK REACH.

• From: Department for Environment, Food & Rural Affairs
• Published: 12 August 2024

Documents

UK REACH authorisations for Siemens Healthcare Diagnostics Products GmbH

PDF, 225 KB, 7 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Decision on an application for authorisations under UK REACH. 

Substance name 

4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (4-tert-OPnEO). 

Authorised uses

Use of 4-tert-OPnEO in in-vitro diagnostic (IVD) kit reagents on diagnostic analyser systems used in controlled settings by professional users such as hospitals and pharmacies. 

Use of 4-tert-OPnEO as a cleaning surfactant in IVD wash solutions on diagnostic analyser systems to ensure their continued accuracy in controlled settings by professional users such as hospitals and pharmacies. 

Holder of the authorisations and authorisation numbers 

Siemens Healthcare Diagnostics Products GmbH (UKREACH/24/06/0, UKREACH/24/06/1). 

Date of decision 

3 July 2024.

Published 12 August 2024